Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 378

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Nonselective β Blockers Increase Risk for Hepatorenal Syndrome and Death in Patients With Cirrhosis and Spontaneous Bacterial Peritonitis

Mandorfer, Mattias, Bota, Simona, Schwabl, Philipp, Bucsics, Theresa, Pfisterer, Nikolaus, Kruzik, Matthias, Hagmann, Michael, Blacky, Alexander, Ferlitsch, Arnulf, Sieghart, Wolfgang, Trauner, Michael, Peck-Radosavljevic, Markus, Reiberger, Thomas·2014·Gastroenterology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2014.03.005

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 33 references

Research works printed but not linked: 9

  1. Krag, 2012, Betablockers induce cardiac chronotropic incompetence, J Hepatol, 56, 298, 10.1016/j.jhep.2011.04.033 · doi:10.1016/j.jhep.2011.04.033
  2. Bendtsen, 1991, Propranolol and haemodynamic response in cirrhosis, J Hepatol, 13, 144, 10.1016/0168-8278(91)90807-N · doi:10.1016/0168-8278(91)90807-n
  3. Wong, 2010, Beta-blockers in cirrhosis: friend and foe?, Hepatology, 52, 811, 10.1002/hep.23852 · doi:10.1002/hep.23852
  4. Kurt, 2011, Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites, Hepatology, 53, 1411, 10.1002/hep.24051 · doi:10.1002/hep.24051
  5. Lo, 2011, Effects of beta-blockers on survival for patients with cirrhosis and refractory ascites, Hepatology, 53, 1068, 10.1002/hep.23986 · doi:10.1002/hep.23986
  6. Agustin, 2011, Beta-blockers in patients with cirrhosis and refractory ascites, Hepatology, 53, 1783, 10.1002/hep.24032 · doi:10.1002/hep.24032
  7. Robins A, Bowden A, Watson W, et al. Propranolol at modest doses does not impair survival in patients with cirrhosis and refractory ascites. Hepatology in press.
  8. Galbois, 2011, Beta-blockers have no effect on outcomes in patients with cirrhosis and severe infections, Hepatology, 53, 1412, 10.1002/hep.24053 · doi:10.1002/hep.24053
  9. Efe, 2011, The deleterious effects of propranolol on patients with cirrhosis, Hepatology, 53, 371, 10.1002/hep.23881 · doi:10.1002/hep.23881

Cited by

See all 378

Metadata

Authors
Mandorfer, M., Bota, S., Schwabl, P., Bucsics, T., Pfisterer, N., Kruzik, M., Hagmann, M., Blacky, A., Ferlitsch, A., Sieghart, W., Trauner, M., Peck-Radosavljevic, M., & Reiberger, T.
Venue
Gastroenterology
Publisher
Elsevier BV
Published
2014-06
Volume
146
Issue
7
Pages
1680-1690.e1
ISSN
0016-5085 (ISSN-L)
OpenAlex
W2108321458
Cited by
378
References
33
FWCI
23.99
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Nonselective β Blockers Increase Risk for Hepatorenal Syndrome and Death in Patients With Cirrhosis and Spontaneous Bacterial Peritonitis. https://app.cochat.ai/papers/10.1053/j.gastro.2014.03.005
The paper
Mandorfer, M., Bota, S., Schwabl, P., Bucsics, T., Pfisterer, N., Kruzik, M., Hagmann, M., Blacky, A., Ferlitsch, A., Sieghart, W., Trauner, M., Peck-Radosavljevic, M., & Reiberger, T. (2014). Nonselective β Blockers Increase Risk for Hepatorenal Syndrome and Death in Patients With Cirrhosis and Spontaneous Bacterial Peritonitis. Gastroenterology. https://doi.org/10.1053/j.gastro.2014.03.005

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.